AcquisitionOther
Ligand Pharmaceuticals acquired XOMA Royalty
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Ligand Pharmaceuticals -> XOMA Royalty · approximately $739 million
To expand royalty portfolio to over 200 assets, accelerate profitable growth, and strengthen position as leading biopharma royalty aggregator.
Open source record (SEC) ↗